Global Glaucoma Surgery Devices Market 2023: Initiatives to Reduce Burden of Glaucoma Fuel Sector
16 mars 2023 07h28 HE
|
Research and Markets
Dublin, March 16, 2023 (GLOBE NEWSWIRE) -- The "Global Glaucoma Surgery Devices Market (2023-2028) by Product, Surgery Method, End-Users, and Geography, Competitive Analysis, Impact of Covid-19,...
Vision Care Market Share Report ($98.96 Billion by 2028) Lead by Eyeglasses Segment - Exclusive Report by The Insight Partners
28 févr. 2023 08h25 HE
|
The Insight Partners
New York, Feb. 28, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Vision Care Market Size, Share, Growth, Trends and Global Forecast to 2028 - COVID-19 Impact and Global Analysis By...
SpyGlass Pharma Unveils 6-Month Data from the First-In-Human Trial of Its Innovative Drug Delivery Platform for Chronic Eye Conditions
03 févr. 2023 11h15 HE
|
SpyGlass Pharma, Inc.
ALISO VIEJO, Calif., Feb. 03, 2023 (GLOBE NEWSWIRE) -- SpyGlass Pharma, a privately held ophthalmic therapeutics company, released 6-month data from a First-in-Human glaucoma treatment trial showing...
Optometry Equipment Market Size is Expected to Reach $7.81 Billion by 2031: Says AMR
30 janv. 2023 08h00 HE
|
Allied Market Research
Portland, OR, Jan. 30, 2023 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Optometry Equipment Market was estimated at $4.24 billion in 2021 and is...
Pii Congratulates Skye Bioscience for First-in-Human Phase 1 Trial of Proprietary Cannabinoid Derivative and Nanoemulsion Formulation Designed to Potentially Treat Glaucoma.
24 janv. 2023 08h00 HE
|
Pharmaceutics International Inc.
Hunt Valley, MD, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Pharmaceutics International, Inc. (Pii), a contract development and manufacturing organization (CDMO), proudly celebrates a first-in-human Phase I...
12-month clinical results of a novel micro-interventional bio-stenting procedure published in the British Journal of Ophthalmology
23 janv. 2023 08h00 HE
|
Iantrek, Inc.
WHITE PLAINS, N.Y., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Iantrek today announced the publication of 12-month clinical results of a novel bio-stenting procedure using the company’s microsurgical...
Wilmington Eye Ophthalmic Surgeon Implants First-Ever Glaucoma Device in the Carolinas
21 déc. 2022 11h00 HE
|
Wilmington Eye
WILMINGTON, N.C., Dec. 21, 2022 (GLOBE NEWSWIRE) -- Today, Wilmington Eye announced Dr. Robert van der Vaart, a board-certified ophthalmic surgeon and glaucoma expert, has successfully implanted the...
iSTAR Medical Expands Commercial Rollout of MINIject with First Surgeries in Sweden and Norway
01 déc. 2022 03h00 HE
|
iSTAR Medical
For immediate release iSTAR Medical Expands Commercial Rollout of MINIject with First Surgeries in Sweden and Norway The only commercially available MIGS device currently targeting the supraciliary...
Investigational Optejet® Microdose Dispenser from Eyenovia Shows Promise in Improving Treatment for Myopia, Presbyopia and Patients Getting Eye Exams
17 oct. 2022 09h01 HE
|
Eyenovia
NEW YORK, Oct. 17, 2022 (GLOBE NEWSWIRE) -- Two recent studies show that the novel Optejet® dispenser from Eyenovia, Inc., an ophthalmic pharmaceutical technology company, may be a more...
Eyenovia Chairman Dr. Sean Ianchulev: The Making Of An iDoctor - Immigrant, Innovator, Inventor
21 sept. 2022 10h01 HE
|
Eyenovia
NEW YORK, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Before founding Eyenovia, Dr. Sean Ianchulev had established himself as a pioneer and innovator in the field of ophthalmology. Inspired by his mother, a...